Advertisement
Home »

Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey.

Jul 17, 2023

ABOUT THE EXPERTS

  • M Weiss

    Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

    Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University, Erlangen, Germany.

    M T Holzer

    III. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. m.holzer@uke.de.

    F Muehlensiepen

    Faculty of Health Sciences, Center for Health Services Research, Brandenburg Medical School Theodor Fontane, Rüdersdorf, Germany.

    Y Ignatyev

    Faculty of Health Sciences, Center for Health Services Research, Brandenburg Medical School Theodor Fontane, Rüdersdorf, Germany.

    C Fiehn

    Praxis für Rheumatologie, Klinische Immunologie, Medical Center, Baden-Baden, Germany.

    J Bauhammer

    Praxis für Rheumatologie, Klinische Immunologie, Medical Center, Baden-Baden, Germany.

    J Schmidt

    Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.

    Department of Neurology and Pain Treatment, Center for Translational Medicine, Neuromuscular Center, Immanuel Klinik Rüdersdorf, University Hospital of the Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.

    Department of Neurology, Neuromuscular Center, University Medical Center, Göttingen, Germany.

    S Schlüter

    Myositis-Gruppe, Deutsche Gesellschaft Für Muskelkranke, Freiburg, Germany.

    A Dihkan

    The Swedish Working Group for Myositis, The Swedish Rheumatism Association, Stockholm, Sweden.

    D Scheibner

    Myositis-Gruppe, Deutsche Gesellschaft Für Muskelkranke, Freiburg, Germany.

    U Schneider

    Department of Rheumatology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

    L Valor-Mendez

    Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

    Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University, Erlangen, Germany.

    G Corte

    Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

    Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University, Erlangen, Germany.

    L Gupta

    Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.

    Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK.

    Department of Rheumatology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.

    H Chinoy

    Department of Rheumatology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK.

    Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

    I Lundberg

    Division of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden.

    Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.

    L Cavagna

    Rheumatology Division, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy.

    J H W Distler

    Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

    Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University, Erlangen, Germany.

    G Schett

    Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

    Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University, Erlangen, Germany.

    J Knitza

    Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

    Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University, Erlangen, Germany.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement